continuation requires symptom improvement Plans excluding "anti-obesity agents" may still deny OSA coverage Independence Blue Cross (PA) Starting January 1, 2025, Independence Blue Cross stopped coverage for GLP-1s prescribed solely for weight loss
Any severe reaction warrants a call to your doctor
Group Three: Youre at a healthy weight If youre lean, metabolically healthy, and not diabetic, the answer is simpler and less satisfying: we have essentially no cancer data on you
If side effects are intolerable at a new dose, the standard approach is to drop back to the previous dose for 2 more weeks before attempting the increase again
Variability in assay platforms, sensitivity, and patient heterogeneity further complicates cross-study comparisons
Chello M , Patti G , Candura D , et al